The American journal of medicine, 2022-07, Vol.135 (7), p.836-839
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- New Drugs Approved in 2021
- Ist Teil von
- The American journal of medicine, 2022-07, Vol.135 (7), p.836-839
- Ort / Verlag
- United States: Elsevier Inc
- Erscheinungsjahr
- 2022
- Quelle
- Elsevier ScienceDirect Journals Complete
- Beschreibungen/Notizen
- In 2021, the US Food and Drug Administration (FDA) approved 50 novel drugs. Thirty-seven of the 50 (74%) novel drug approvals were reviewed and approved through an expedited review pathway, and 26 of the 50 (52%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2021.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0002-9343eISSN: 1555-7162DOI: 10.1016/j.amjmed.2022.01.055Titel-ID: cdi_proquest_miscellaneous_2635474839
- Format
- –
- Schlagworte
- Accelerated approval, Fast track, FDA, Novel drugs, Priority review